New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!
Ronald M.  Lombardi net worth and biography

Ronald Lombardi Biography and Net Worth

Ronald M. Lombardi was elected Chairman of the Board in May 2017 and has served as a director and as President and Chief Executive Officer of the Company since June 2015. He served as Chief Financial Officer of the Company from December 2010 until November 2015. Prior to joining the Company, from October 2010 to December 2010, Mr. Lombardi was employed by Medtech Group Holdings, a components and contract medical device manufacturer, as Chief Financial Officer. From October 2009 to October 2010, Mr. Lombardi served as the Chief Financial Officer of Waterbury International Holdings, a specialty chemical and pest control business. Mr. Lombardi was employed by Cannondale Sports Group, a sporting goods and apparel manufacturing company, as Chief Operating Officer from August 2008 to October 2009 and as Senior Vice President and Chief Financial Officer from March 2004 to August 2008. From 2000 to 2004, Mr. Lombardi served in various roles at Gerber Scientific Inc., including Vice President and Chief Financial Officer of Gerber Scientific Inc.’s Gerber Coburn Optical Division and Director of Financial Planning and Analysis of Gerber Scientific Inc. Mr. Lombardi was also previously employed by Emerson Electric, Scovill Fasteners, Inc. and Go/Dan Industries. Mr. Lombardi currently serves as Chair of the Audit Committee on the board of ACCO Brands Corporation.

Mr. Lombardi received a B.S. from Springfield College and an M.B.A. from American International College and has been a licensed CPA.

What is Ronald M. Lombardi's net worth?

The estimated net worth of Ronald M. Lombardi is at least $16.23 million as of August 8th, 2023. Mr. Lombardi owns 270,557 shares of Prestige Consumer Healthcare stock worth more than $16,225,303 as of December 6th. This net worth evaluation does not reflect any other assets that Mr. Lombardi may own. Additionally, Mr. Lombardi receives an annual salary of $1,980,000.00 as Insider at Prestige Consumer Healthcare. Learn More about Ronald M. Lombardi's net worth.

How old is Ronald M. Lombardi?

Mr. Lombardi is currently 59 years old. There are 4 older executives and no younger executives at Prestige Consumer Healthcare. Learn More on Ronald M. Lombardi's age.

What is Ronald M. Lombardi's salary?

As the Insider of Prestige Consumer Healthcare Inc., Mr. Lombardi earns $1,980,000.00 per year. Learn More on Ronald M. Lombardi's salary.

How do I contact Ronald M. Lombardi?

The corporate mailing address for Mr. Lombardi and other Prestige Consumer Healthcare executives is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. Prestige Consumer Healthcare can also be reached via phone at (914) 524-6800 and via email at [email protected]. Learn More on Ronald M. Lombardi's contact information.

Has Ronald M. Lombardi been buying or selling shares of Prestige Consumer Healthcare?

Ronald M. Lombardi has not been actively trading shares of Prestige Consumer Healthcare during the past quarter. Most recently, Ronald M. Lombardi sold 32,800 shares of the business's stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $65.57, for a transaction totalling $2,150,696.00. Following the completion of the sale, the chief executive officer now directly owns 270,557 shares of the company's stock, valued at $17,740,422.49. Learn More on Ronald M. Lombardi's trading history.

Who are Prestige Consumer Healthcare's active insiders?

Prestige Consumer Healthcare's insider roster includes Mary Beth Fritz (SVP), and Ronald Lombardi (Insider). Learn More on Prestige Consumer Healthcare's active insiders.

Are insiders buying or selling shares of Prestige Consumer Healthcare?

In the last year, insiders at the sold shares 2 times. They sold a total of 35,340 shares worth more than $2,300,352.80. The most recent insider tranaction occured on September, 14th when SVP Mary Beth Fritz sold 2,540 shares worth more than $149,656.80. Insiders at Prestige Consumer Healthcare own 1.6% of the company. Learn More about insider trades at Prestige Consumer Healthcare.

Information on this page was last updated on 9/14/2023.

Ronald M. Lombardi Insider Trading History at Prestige Consumer Healthcare

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/8/2023Sell32,800$65.57$2,150,696.00270,557View SEC Filing Icon  
11/12/2021Sell52,367$62.78$3,287,600.26View SEC Filing Icon  
5/12/2020Sell29,593$40.00$1,183,720.00154,630View SEC Filing Icon  
2/5/2018Buy7,000$35.94$251,580.00138,969View SEC Filing Icon  
2/10/2015Sell22,400$38.89$871,136.00View SEC Filing Icon  
9/15/2014Sell600$33.23$19,938.00View SEC Filing Icon  
See Full Table

Ronald M. Lombardi Buying and Selling Activity at Prestige Consumer Healthcare

This chart shows Ronald M Lombardi's buying and selling at Prestige Consumer Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Prestige Consumer Healthcare Company Overview

Prestige Consumer Healthcare logo
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Read More

Today's Range

Now: $59.91
Low: $59.74
High: $60.44

50 Day Range

MA: $58.87
Low: $57.00
High: $61.40

2 Week Range

Now: $59.91
Low: $55.96
High: $68.54


36,129 shs

Average Volume

239,581 shs

Market Capitalization

$2.97 billion

P/E Ratio


Dividend Yield